Literature DB >> 27803970

The Maximal Expiratory-to-Inspiratory Pressure Ratio and Supine Vital Capacity as Screening Tests for Diaphragm Dysfunction.

Patrick Koo1, Dennis O Oyieng'o1, Eric J Gartman1, Jigme M Sethi1, Charles B Eaton2, F Dennis McCool3.   

Abstract

PURPOSE: The change in vital capacity from the seated to supine position (∆VC-supine) is used to screen for diaphragm dysfunction (DD), but some individuals are unable to tolerate the supine position. Since expiratory muscle function is often preserved in patients with isolated DD and inspiratory strength is reduced, the purpose of this study was to examine if the ratio of maximal expiratory pressure to maximal inspiratory pressure (MEP/MIP) may provide an alternative to ∆VC-supine when screening patients for DD.
METHODS: We performed a cross-sectional analysis on 76 patients referred for evaluation of unexplained dyspnea and possible DD. MEP and MIP were measured in the seated position as well as the percent change in VC from the seated to supine position (∆VC-supine %). The presence of unilateral diaphragm paralysis (UDP), bilateral diaphragm paralysis (BDP), or normal diaphragm function (N) was confirmed by ultrasound.
RESULTS: Of the 76 patients, 23 had N, 40 had UDP, and 13 had BDP. MEP/MIP was significantly greater for UDP compared to N (2.1(1.2-5.7) and 1.5(0.7-2.2), respectively) (median and interquartile range) and for BDP compared to UDP (4.3(2.3-7.5) and 2.1(1.2-5.7), respectively) (p < 0.001). The area (AUC) under the receiver-operating characteristic curve for MEP/MIP between N and UDP was 0.84 (95% confidence interval (CI) 0.74-0.94) and between UDP and BDP was 0.90 (95% CI 0.80-0.99). MEP/MIP had a strong monotonic relationship with ∆VC-supine % (Spearman's ρ = 0.68, p < 0.001).
CONCLUSIONS: The MEP/MIP ratio provides a method with comparable sensitivity and specificity to ∆VC-supine % that can be used to screen patients with suspected isolated phrenic neuropathy and alleviates the need for measuring supine pulmonary function.

Entities:  

Keywords:  Diaphragm; Diaphragm paralysis; Pulmonary function testing; Respiratory measurement; Respiratory muscles

Mesh:

Year:  2016        PMID: 27803970     DOI: 10.1007/s00408-016-9959-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  26 in total

1.  ATS/ERS Statement on respiratory muscle testing.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-08-15       Impact factor: 21.405

Review 2.  Disorders of the respiratory muscles.

Authors:  Franco Laghi; Martin J Tobin
Journal:  Am J Respir Crit Care Med       Date:  2003-07-01       Impact factor: 21.405

Review 3.  Dysfunction of the diaphragm.

Authors:  F Dennis McCool; George E Tzelepis
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

Review 4.  Diaphragmatic paresis: pathophysiology, clinical features, and investigation.

Authors:  G J Gibson
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

Review 5.  Coming together: the ATS/ERS consensus on clinical pulmonary function testing.

Authors:  V Brusasco; R Crapo; G Viegi
Journal:  Eur Respir J       Date:  2005-07       Impact factor: 16.671

6.  Diaphragm ultrasound as a predictor of successful extubation from mechanical ventilation.

Authors:  Ernest DiNino; Eric J Gartman; Jigme M Sethi; F Dennis McCool
Journal:  Thorax       Date:  2013-12-23       Impact factor: 9.139

7.  Inspiratory muscle function in unilateral diaphragmatic paralysis.

Authors:  C Lisboa; P D Paré; J Pertuzé; G Contreras; R Moreno; S Guillemi; E Cruz
Journal:  Am Rev Respir Dis       Date:  1986-09

8.  Diaphragm strength in patients with recent hemidiaphragm paralysis.

Authors:  C M Laroche; A K Mier; J Moxham; M Green
Journal:  Thorax       Date:  1988-03       Impact factor: 9.139

9.  Measurement of respiratory muscle forces based on maximal inspiratory and expiratory pressures.

Authors:  J Karvonen; S Saarelainen; M M Nieminen
Journal:  Respiration       Date:  1994       Impact factor: 3.580

10.  Clinical significance of severe isolated diaphragm weakness.

Authors:  C M Laroche; N Carroll; J Moxham; M Green
Journal:  Am Rev Respir Dis       Date:  1988-10
View more
  6 in total

1.  When nerves fail: A cause of respiratory failure in a diabetic patient.

Authors:  Muhammad Talha Ayub; Tooba Ayub; Wajeeha Rasool; Muhammad Shoaib Khan; Muhammad Ishaq; Benjamin Mba
Journal:  Caspian J Intern Med       Date:  2022

2.  Effectiveness of inspiratory muscle training (IMT) on pulmonary function and functional capacity in chronic smoker's v/s non-smokers patients undergoing open abdominal surgery - A study protocol.

Authors:  Shah Khyati; Sampath Kumar Amaravdi; Stephen Rajan Samuel; Alfred J Augustine; Vijaypratap Singh
Journal:  Int J Surg Protoc       Date:  2020-11-06

3.  Unilateral diaphragmatic paralysis: inspiratory muscles, breathlessness and exercise capacity.

Authors:  Mayra Caleffi Pereira; Letícia Z Cardenas; Jeferson G Ferreira; Vinícius C Iamonti; Pauliane Vieira Santana; André Apanavicius; Pedro Caruso; Angelo Fernandez; Carlos R R de Carvalho; Daniel Langer; André L P de Albuquerque
Journal:  ERJ Open Res       Date:  2021-02-01

4.  RESPIRATORY MUSCLE IMPAIRMENT EVALUATED WITH MEP/MIP RATIO IN CHILDREN AND ADOLESCENTS WITH CHRONIC RESPIRATORY DISEASE.

Authors:  Iván Rodríguez-Núñez; Gerardo Torres; Soledad Luarte-Martinez; Carlos Manterola; Daniel Zenteno
Journal:  Rev Paul Pediatr       Date:  2020-12-18

5.  A retrospective cohort study of idiopathic diaphragmatic palsy: a diagnostic triad, natural history and prognosis.

Authors:  Syeda Nafisa; Ben Messer; Beatrice Downie; Patience Ehilawa; William Kinnear; Sherif Algendy; Milind Sovani
Journal:  ERJ Open Res       Date:  2021-09-13

6.  Ultrasound-assessed diaphragm dysfunction predicts clinical outcomes in hemodialysis patients.

Authors:  Jing Zheng; Qing Yin; Shi-Yuan Wang; Ying-Yan Wang; Jing-Jie Xiao; Tao-Tao Tang; Wei-Jie Ni; Li-Qun Ren; Hong Liu; Xiao-Liang Zhang; Bi-Cheng Liu; Bin Wang
Journal:  Sci Rep       Date:  2022-10-03       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.